- Report
- October 2024
- 198 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- November 2024
- 120 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- January 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- July 2024
- 160 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- August 2022
- 113 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2019
- 348 Pages
Global
From €4218EUR$4,400USD£3,524GBP
- Training
- 2 Hours
Global
The Rapid Oral Fluid Drug Test market is a subset of the Drug Abuse Screening market, which is used to detect the presence of drugs in a person's system. Rapid Oral Fluid Drug Tests are a type of drug test that uses saliva to detect the presence of drugs in a person's system. These tests are typically used to detect the presence of drugs such as marijuana, cocaine, amphetamines, and opiates. They are often used in workplace drug testing, as well as in criminal justice settings.
Rapid Oral Fluid Drug Tests are typically easy to administer and provide results in a short amount of time. They are also relatively inexpensive compared to other drug testing methods. Additionally, they are less invasive than other drug testing methods, as they do not require a blood sample.
Some companies in the Rapid Oral Fluid Drug Test market include Alere, Abbott, Siemens, and Roche. Show Less Read more